Literature DB >> 8876633

Papillomavirus infections--a major cause of human cancers.

H zur Hausen1.   

Abstract

The papillomavirus family represents a remarkably heterogeneous group of viruses. At present, 77 distinct genotypes have been identified in humans and partial sequences have been obtained from more than 30 putative novel genotypes. Geographic differences in base composition of individual genotypes are generally small and suggest a low mutation rate and thus an ancient origin of today's prototypes. The relatively small size of the genome permitted an analysis of individual gene functions and of interactions of viral proteins with host cell components. Proliferating cells contain the viral genome in a latent form, large scale viral DNA replication, as well as translation and functional activity of late viral proteins, and viral particle assembly are restricted to differentiating layers of skin and mucosa. In humans papillomavirus infections cause a variety of benign proliferations: warts, epithelial cysts, intraepithelial neoplasias, anogenital, oro-laryngeal and -pharyngeal papillomas, keratoacanthomas and other types of hyperkeratoses. Their involvement in the etiology of some major human cancers is of particular interest: specific types (HPV 16, 18 and several others) have been identified as causative agents of at least 90% of cancers of the cervix and are also linked to more than 50% of other anogenital cancers. These HPV types are considered as 'high risk' infections. Their E6/E7 oncoproteins stimulate cell proliferation by activating cyclins E and A, and interfere with the functions of the cellular proteins RB and p53. The latter interaction appears to be responsible for their mutagenic and aneuploidizing activity as an underlying principle for the progression of these HPV-containing lesions and the role of high risk HPV types as solitary carcinogens. In non-transformed human keratinocytes transcription and function of viral oncoproteins is controlled by intercellular and intracellular signalling cascades, their interruption emerges as a precondition for immortalization and malignant growth. Recently, novel and known HPV types have also been identified in a high percentage of non-melanoma skin cancers (basal and squamous cell carcinomas). Similar to observations in patients with a rare hereditary condition, epidermodysplasia verruciformis, characterized by an extensive verrucosis and development of skin cancer, basal and squamous cell carcinomas develop preferentially in light-exposed sites. This could suggest an interaction between a physical carcinogen (UV-part of the sunlight) and a 'low risk' (non-mutagenic) papillomavirus infection. Reports on the presence of HPV infections in cancers of the oral cavity, the larynx, and the esophagus further emphasize the importance of this virus group as proven and suspected human carcinogens.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8876633     DOI: 10.1016/0304-419x(96)00020-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  395 in total

1.  The E8 domain confers a novel long-distance transcriptional repression activity on the E8E2C protein of high-risk human papillomavirus type 31.

Authors:  F Stubenrauch; T Zobel; T Iftner
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.

Authors:  A M Helt; D A Galloway
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  DNA bending by an adenine--thymine tract and its role in gene regulation.

Authors:  J Hizver; H Rozenberg; F Frolow; D Rabinovich; Z Shakked
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

4.  Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7.

Authors:  S L Gonzalez; M Stremlau; X He; J R Basile; K Münger
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  A novel strategy for human papillomavirus detection and genotyping with SybrGreen and molecular beacon polymerase chain reaction.

Authors:  K Szuhai; E Sandhaus; S M Kolkman-Uljee; M Lemaître; J C Truffert; R W Dirks; H J Tanke; G J Fleuren; E Schuuring; A K Raap
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

6.  An apparent outbreak of cutaneous papillomatosis in merino sheep in patagonia, Argentina.

Authors:  F A Uzal; A Latorraca; M Ghoddusi; M Horn; M Adamson; W R Kelly; R Schenkel
Journal:  Vet Res Commun       Date:  2000-04       Impact factor: 2.459

7.  Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients.

Authors:  R J Berkhout; J N Bouwes Bavinck; J ter Schegget
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

8.  Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells.

Authors:  Anna-Marija Helt; Jens Oliver Funk; Denise A Galloway
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Human keratinocyte cultures in the investigation of early steps of human papillomavirus infection.

Authors:  Laura M Griffin; Louis Cicchini; Tao Xu; Dohun Pyeon
Journal:  Methods Mol Biol       Date:  2014

10.  Retrospective analysis of HPV 16/18-related disease burden using archival clinical samples.

Authors:  Naureen Ehsan Ilahi; Shoaib Naiyar Hashmi; Sobia Anwar; Sheeba Murad
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-30       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.